Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 3/2010

01-10-2010 | Poster presentation

An audit to assess the impact of introducing a protocol of bilateral whole breast and axillary ultrasound for assessment of screen-detected cancers

Authors: IT Perera, LS Wilkinson

Published in: Breast Cancer Research | Special Issue 3/2010

Login to get access

Excerpt

Our protocol for assessment of women with screen-detected malignancy was changed to include bilateral whole breast and axillary ultrasound (BBUS) following a prospective study that confirmed the benefit of this in 2002 [1]. This audit assesses the impact of introducing this change. …
Literature
1.
Wilkinson LS, Given-Wilson R, Hall T, Potts H, Sharma AK, Smith E: Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol. 2005, 60: 573-578. 10.1016/j.crad.2004.10.015.CrossRefPubMed
2.
Metadata
Title
An audit to assess the impact of introducing a protocol of bilateral whole breast and axillary ultrasound for assessment of screen-detected cancers
Authors
IT Perera
LS Wilkinson
Publication date
01-10-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 3/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2682

Other articles of this Special Issue 3/2010

Breast Cancer Research 3/2010 Go to the issue

Poster presentation

Initial experience with MicroPure™, a new ultrasound image processing function to improve calcification visualisation

Poster presentation

Comparison of 1.5T and 3T in assessment of suspicious breast lesions

Poster presentation

Is digital better?

Poster presentation

Benefits of CT-angiography localisation in the surgical planning of deep inferior epigastric perforator flap breast reconstruction

Poster presentation

Incident cancer cases: what can we learn from the previous screening round?

Oral presentation

MR visible only lesions: what are the predictors for malignant outcome?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits